<DOC>
	<DOCNO>NCT02202668</DOCNO>
	<brief_summary>The primary translational research objective study demonstrate feasibility use Transcutaneous Raman Spectroscopy technology point-of-care environment . This study represent initial evaluation device small cohort human patient diabetic foot ulcer . We evaluate safety , device design certain human engineering factor associate point care use TRS . We anticipate data collect study form basis later medical device study .</brief_summary>
	<brief_title>Transcutaneous Raman Spectroscope ( TRS ) Analyses Diabetic Foot Ulcers</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Diabetic Foot</mesh_term>
	<mesh_term>Foot Ulcer</mesh_term>
	<criteria>Ability provide inform consent Diagnosis diabetes mellitus Full thickness superficial foot ankle ulcer base clinical assessment ( e.g. , University Texas ( UT ) grade 13 , stage AD ) . For reference , see Appendix 1 UT classification table Age le 18 great 80 year old Subject psychological sociological condition addictive disorder would preclude informed consent Completely epithelialized ulcer base clinical assessment ischemia infection ( UT classification 0A ) Current previous use antiresorptive bisphosphonate drug ( e.g. , risedronate ( Actonel ) alendronate ( Fosamax ) )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>Foot ulcer , diabetic</keyword>
	<keyword>Spectrum analysis , Raman</keyword>
</DOC>